Farklı kalp hastalığı tanılı Türk kadınların cinsel fonksiyonlarının hastalık öncesi ve sonrası eşleri ile birlikte değerlendirilmesi: Kontrol gruplu çalışma

AMAÇ: Farklı kalp hastalığı olan Türk kadınları ve eşlerinin cinsel yaşamları sorgulanacaktır. Hastalık öncesi, sonrası ve kontrol grubuyla farklar değerlendirilecek. GEREÇ ve YÖNTEM: Hastaların ve eşlerin ürolojik, hastaların kardiolojik, kadın doğum muayeneleri yapıldı. Tümünün hormonal, biokimyasal, mikrobiolojik değerlerine bakıldı. Beck depresyon envanteri (BDÖ) ile psikolojik durumları değerlendirildi. Kalp hastası kadınların Eastern Cooperative Oncology Group (ECOG) ile fiziksel performansları değerlendirildi. Kadın cinsel işlev ölçeği (FSFI), uluslar arası erektil işlev formu (IIEF) Türkçe versiyonu ile cinsel yaşamları sorgulanıldı. BDÖ >17 olan hastalar çalışmaya alınılmadı. BULGULAR: Anjina pektoris, anjio, stent, kalp pili, bypass cerrahisi, mitral, aort kapak cerrahisi, akut myokard infaktüsü, konjestif kalp yetmezliği, kardiomyopati tanılı n=60 kadın incelenildi. Menopoz, kalp hastalığı ve ek komorbiditesi olmayan n=45 kadın ve eşleri kontrol grubu olarak seçildi. Hastalar ve kontrol grubunda erkek yaşları, menstrial siklus, sigara içme oranı, FSH, LH, E2, PRL, TT, TSH, ST3, ST4 değerlerinde anlamlı (p>0,05) farklılıklar gözlenilmedi. ECOG derecesi kontrol grubunda p

Assessment of sexual functions of Turkish women with different heart diseases before and after disease with their spouses: A study with a control group

OBJECTIVE: The sexual lives of Turkish women with different heart disease and their spouses will be questioned. Differences will be evaluated with the control group before and after the disease. MATRERIAL and METHOD: The patients and their spouses underwent urological examinations and cardiological and obstetrics examinations of patients were performed. The hormonal, biochemical and microbiological values of all patients and their spouses were examined. Their psychological status was evaluated with Beck Depression Inventory (BDI). Physical performance of women with heart disease was evaluated with Eastern Cooperative Oncology Group (ECOG). Their sexual lives were assessed with the Turkish version of the Female Sexual Function Scale (FSFI) and the International Erectile Function (IIEF) form. Both male and female patients with BDI >17 were excluded from the study. RESULTS: A total of n=60 women with angina pectoris, who underwent angiogram, stent, pacemaker, bypass surgery, mitral, aortic valve surgery, had acute myocardial infarction, congestive heart failure, and cardiomyopathy were studied. N=45 women without menopause, heart disease and additional comorbidities and their spouses were selected as the control group. In patients and control groups, no significant differences were observed in terms of the age of men, menstrual cycle, smoking rate, FSH, LH, E2, PRL, TT, TSH, ST3 and ST4 values. The ECOG rate was higher than p

Kaynakça

1. DeBusk R, Drory Y, Goldstein I, Jackson G, Kaul S, Kimmel S, et al. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. Am J Cardiol 2000;86:175–81. [CrossRef ]

2. Schwarz ER, Kapur V, Bionat S, Rastogi S, Gupta R, Rosanio S. The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure. Int J Impotence Res 2008;20:85–91. [CrossRef ]

3. Vicdan N, Özer Z. Miyokard İnfarktüsü ve Cinsel İşlev Bozukluğu. Türk Kardiol Dern Kardiyovasküler Hemşirelik Derg 2011;2:2–6. [CrossRef ]

4. Yıldız H, Pınar R. Miyokard İnfarktüslü Hastalarda Cinsel Disfonksiyon. Anadolu Kardiol Derg 2004;4:309– 17. https://www.journalagent.com/anatoljcardiol/pdfs/ AnatolJCardiol_4_4_309_317.pdf

5. Hoekstra T, Jaarsma T, Sanderman R, van Veldhuisen, DJ, Lesman- Leegte I. Perceived sexual difficulties and associated factors in patients with heart failure. Am Heart J 2012;163:246–51. [CrossRef]

6. Nusbaum MR, Helton MR, Ray N. The changing nature of women’s sexual health concerns through the midlife years. Maturitas 2004;49:283–91. [CrossRef ]

7. Beck AT. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–71. [CrossRef ]

8. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and Response Criteria of The Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649–55. https://pubmed.ncbi.nlm.nih.gov/7165009/

9. DeBusk R, Drory Y, Goldstein I, Jackson G, Kaul S, Kimmel S, et al. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000;86:175–81. [CrossRef ]

10. Metin A, Kayıgil Ö. Kardiyovasküler problemi olan hastalarda cinsel fonksiyonun sağlanması. Erkek cinsel sağlığı. Androloji Bült 2004;16:10–2. http://file.lookus.net/ androlojibulteni/%C5%9Eubat-2004-16.Say%C4%B1.pdf

11. Hamilton GA, Seidman RN. A comparison of the recovery period for women and men after myocardial infarction. Heart Lung 1992;22:308–15. https://pubmed.ncbi.nlm.nih.gov/8360065/

12. Beutel ME, Stöbel-Richter Y, Brahler E. Sexual desire and sexual activity of men and women across their lifespans: results from a representative German community survey. BJU Int 2008;101:76– 82. [CrossRef ]

13. DeLamater J. Sexual expression in later life: a review and synthesis. J Sex Res 2012;49:125–141. [CrossRef ]

14. Kazemi-Saleh D, Pishgoo B, Farrokhi F, Fotros A, Assari S. Sexual function and psychological status among males and females with ischemic heart disease. J Sex Med 2008;5:2330–7. [CrossRef ]

15. Addis IB, Christine C, Eric V, Feng L, Stuenkel CA, Hulley S. Sexual activity and function in postmenopausal women with heart disease. Obstet Gynecol 2005;106:121–7. [CrossRef ]

16. Schwarz ER, Kapur V, Bionat S, Rastogi S, Gupta R, Rosanio S. The prevalence and clinical relevance of sexual dysfunction in women and men chronic heart failure. Int J Impot Res 2008;20:85–91. [CrossRef ]

17. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited: a comparison of U. S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008;52:1990–6. [CrossRef ]

18. Mickley H, Petersen J, Nielsen BL. Subjective consequences of permanent pacemaker therapy in patients under the age of retirement. Pacing Clin Electrophysiol 1989;12:401–5. [CrossRef ]

19. Stein R, Sardinha A, Aroujo CGS. Sexual Activity and Heart Patients: A Contemporary Perspective. Can J Cardiol 2016;32:410– 20. [CrossRef ]

20. Levine GN, Steinke EE, Bakaeen FG, Bozkurt B, Cheitlin MD, Conti JB, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2012;125:1058–72. [CrossRef ]

21. Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005;96:313–21. [CrossRef ]

22. Lindau ST, Schumm LP, Laumann EO, Levinson W, O’Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762–74. [CrossRef ]

23. Drory Y, Kravetz S, Weingarten M. Comparison of sexual activity of women and men after a first Acute myocardial infarction. Am J Cardiol 2000;85:1283–7. [CrossRef ]

24. Boydak B, Nalbantgil S, Fici F, Nalbantgil I, Zoghi M, Ozerkan F, et al. A randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men [published correction appears in Clin Drug Investig 2007;27:864]. Clin Drug Investig 2005;25:409–16. [CrossRef ]

25. DeLamater JD, Sill M. Sexual desire in later life. J Sex Res 2005;42:138–49. [CrossRef ]

26. Gitlin MJ, Suri R, Altshuler L, Zuckerbrow-Miller J, Fairbanks L. Bupropion- sustained release as a treatment for SSRI-induced sexual side effects. J Sex Marital Ther 2002;28:131–8. [CrossRef ]

27. Ma R, Yu J, Xu D, Yang L, Lin X, Zhao F, Bai F. Effect of felodopine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension. J Hypertens 2012;30:210–16. [CrossRef ]

28. Fogari R, Preti P, Zoppi A, Corradi L, Pasotti C, Rinaldi A, Mugellini A. Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens 2004;17:77–81. [CrossRef ]

29. Kriston L, Guenzler C, Agvemang A, Bengel J, Berner MM. Effect of sexual function on Health-Related Quality of Life Mediated by Depressive Symptoms in Cardiac Rehabilitation. Findings of the SPARK Project in 493 patients. J Sex Medicine 2010;7:2044–55. [CrossRef ]

Kaynak Göster